| 1.0 |
3.0 |
GO:0019886 |
antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
| 0.5 |
1.6 |
GO:0035419 |
activation of MAPK activity involved in innate immune response(GO:0035419) |
| 0.5 |
2.9 |
GO:2000124 |
cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.5 |
3.4 |
GO:0045627 |
regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045423) positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045425) positive regulation of T-helper 1 cell differentiation(GO:0045627) |
| 0.5 |
10.2 |
GO:0002504 |
antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
| 0.4 |
2.2 |
GO:0060292 |
long term synaptic depression(GO:0060292) |
| 0.3 |
18.5 |
GO:0006958 |
complement activation, classical pathway(GO:0006958) |
| 0.3 |
0.9 |
GO:0035608 |
protein deglutamylation(GO:0035608) |
| 0.3 |
0.9 |
GO:0045603 |
positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.3 |
4.7 |
GO:0018298 |
protein-chromophore linkage(GO:0018298) |
| 0.3 |
1.4 |
GO:0071356 |
tumor necrosis factor-mediated signaling pathway(GO:0033209) response to tumor necrosis factor(GO:0034612) cellular response to tumor necrosis factor(GO:0071356) |
| 0.2 |
0.9 |
GO:0006154 |
adenosine catabolic process(GO:0006154) |
| 0.2 |
0.8 |
GO:0051573 |
negative regulation of histone H3-K9 methylation(GO:0051573) |
| 0.2 |
1.0 |
GO:0051902 |
negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
| 0.2 |
0.6 |
GO:0045656 |
negative regulation of monocyte differentiation(GO:0045656) |
| 0.2 |
0.6 |
GO:0033364 |
mast cell secretory granule organization(GO:0033364) |
| 0.2 |
1.7 |
GO:0045078 |
positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
| 0.2 |
0.8 |
GO:0046967 |
cytosol to ER transport(GO:0046967) |
| 0.2 |
0.5 |
GO:0071380 |
cellular response to prostaglandin E stimulus(GO:0071380) |
| 0.2 |
1.1 |
GO:0015755 |
fructose transport(GO:0015755) |
| 0.2 |
0.5 |
GO:0010273 |
detoxification of copper ion(GO:0010273) stress response to copper ion(GO:1990169) |
| 0.1 |
0.4 |
GO:0034122 |
negative regulation of toll-like receptor signaling pathway(GO:0034122) |
| 0.1 |
0.9 |
GO:0060710 |
chorio-allantoic fusion(GO:0060710) |
| 0.1 |
1.0 |
GO:0010459 |
negative regulation of heart rate(GO:0010459) |
| 0.1 |
0.4 |
GO:0006423 |
cysteinyl-tRNA aminoacylation(GO:0006423) |
| 0.1 |
1.2 |
GO:0006546 |
glycine catabolic process(GO:0006546) |
| 0.1 |
2.7 |
GO:0002474 |
antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
| 0.1 |
1.2 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.1 |
0.7 |
GO:0007352 |
zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.1 |
0.6 |
GO:0008588 |
release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
| 0.1 |
1.0 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.1 |
0.3 |
GO:0010792 |
DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
| 0.1 |
1.6 |
GO:0043330 |
response to exogenous dsRNA(GO:0043330) |
| 0.1 |
0.8 |
GO:0021978 |
telencephalon regionalization(GO:0021978) |
| 0.1 |
0.7 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 0.1 |
1.4 |
GO:0071230 |
positive regulation of TOR signaling(GO:0032008) cellular response to amino acid stimulus(GO:0071230) |
| 0.1 |
0.1 |
GO:0046110 |
xanthine metabolic process(GO:0046110) |
| 0.1 |
0.5 |
GO:0071480 |
cellular response to gamma radiation(GO:0071480) |
| 0.1 |
0.3 |
GO:0006408 |
snRNA export from nucleus(GO:0006408) snRNA transport(GO:0051030) |
| 0.1 |
0.9 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 0.1 |
1.5 |
GO:0006700 |
C21-steroid hormone biosynthetic process(GO:0006700) |
| 0.1 |
0.4 |
GO:0018106 |
peptidyl-histidine phosphorylation(GO:0018106) |
| 0.1 |
0.2 |
GO:0031297 |
replication fork processing(GO:0031297) |
| 0.1 |
0.7 |
GO:0051552 |
flavone metabolic process(GO:0051552) |
| 0.1 |
1.9 |
GO:0030224 |
monocyte differentiation(GO:0030224) |
| 0.1 |
0.4 |
GO:0010759 |
regulation of macrophage chemotaxis(GO:0010758) positive regulation of macrophage chemotaxis(GO:0010759) |
| 0.1 |
0.9 |
GO:0046827 |
positive regulation of protein export from nucleus(GO:0046827) |
| 0.1 |
0.7 |
GO:0007141 |
male meiosis I(GO:0007141) |
| 0.1 |
1.2 |
GO:0070206 |
protein trimerization(GO:0070206) |
| 0.1 |
0.4 |
GO:0048296 |
isotype switching to IgA isotypes(GO:0048290) regulation of isotype switching to IgA isotypes(GO:0048296) positive regulation of isotype switching to IgA isotypes(GO:0048298) |
| 0.1 |
1.6 |
GO:0030593 |
neutrophil chemotaxis(GO:0030593) neutrophil migration(GO:1990266) |
| 0.1 |
0.2 |
GO:0043461 |
proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
| 0.1 |
1.1 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.1 |
0.2 |
GO:1901361 |
heterocycle catabolic process(GO:0046700) organic cyclic compound catabolic process(GO:1901361) |
| 0.1 |
1.2 |
GO:0050853 |
B cell receptor signaling pathway(GO:0050853) |
| 0.1 |
1.9 |
GO:0045646 |
regulation of erythrocyte differentiation(GO:0045646) |
| 0.1 |
0.2 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.1 |
0.8 |
GO:0015939 |
pantothenate metabolic process(GO:0015939) |
| 0.1 |
0.4 |
GO:0006572 |
tyrosine catabolic process(GO:0006572) |
| 0.1 |
0.3 |
GO:0060259 |
regulation of feeding behavior(GO:0060259) |
| 0.1 |
0.8 |
GO:0050930 |
induction of positive chemotaxis(GO:0050930) |
| 0.0 |
1.8 |
GO:0018149 |
peptide cross-linking(GO:0018149) |
| 0.0 |
0.2 |
GO:0018352 |
protein-pyridoxal-5-phosphate linkage(GO:0018352) |
| 0.0 |
0.3 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.0 |
0.3 |
GO:0046349 |
UDP-N-acetylglucosamine biosynthetic process(GO:0006048) amino sugar biosynthetic process(GO:0046349) |
| 0.0 |
0.8 |
GO:0008634 |
obsolete negative regulation of survival gene product expression(GO:0008634) |
| 0.0 |
0.1 |
GO:0002681 |
somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) DNA ligation involved in DNA recombination(GO:0051102) |
| 0.0 |
1.3 |
GO:0032024 |
positive regulation of insulin secretion(GO:0032024) |
| 0.0 |
0.7 |
GO:0030260 |
entry into host cell(GO:0030260) entry into host(GO:0044409) entry into cell of other organism involved in symbiotic interaction(GO:0051806) entry into other organism involved in symbiotic interaction(GO:0051828) |
| 0.0 |
3.0 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.0 |
0.3 |
GO:0044245 |
polysaccharide digestion(GO:0044245) |
| 0.0 |
3.3 |
GO:0006521 |
regulation of cellular amino acid metabolic process(GO:0006521) |
| 0.0 |
0.4 |
GO:0060968 |
regulation of gene silencing(GO:0060968) |
| 0.0 |
0.4 |
GO:0035590 |
purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.0 |
0.1 |
GO:0032227 |
negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
| 0.0 |
0.1 |
GO:0050983 |
spermidine catabolic process(GO:0046203) deoxyhypusine biosynthetic process from spermidine(GO:0050983) |
| 0.0 |
0.7 |
GO:0007032 |
endosome organization(GO:0007032) |
| 0.0 |
0.1 |
GO:0043116 |
negative regulation of vascular permeability(GO:0043116) |
| 0.0 |
0.1 |
GO:0060649 |
nipple development(GO:0060618) mammary gland bud elongation(GO:0060649) nipple morphogenesis(GO:0060658) nipple sheath formation(GO:0060659) |
| 0.0 |
0.2 |
GO:0001867 |
complement activation, lectin pathway(GO:0001867) |
| 0.0 |
3.2 |
GO:0008277 |
regulation of G-protein coupled receptor protein signaling pathway(GO:0008277) |
| 0.0 |
0.4 |
GO:0006027 |
glycosaminoglycan catabolic process(GO:0006027) |
| 0.0 |
0.0 |
GO:2000078 |
regulation of type B pancreatic cell development(GO:2000074) positive regulation of type B pancreatic cell development(GO:2000078) |
| 0.0 |
0.1 |
GO:0048496 |
maintenance of organ identity(GO:0048496) |
| 0.0 |
0.6 |
GO:0033540 |
fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.0 |
0.2 |
GO:0045010 |
actin nucleation(GO:0045010) |
| 0.0 |
0.1 |
GO:0043114 |
regulation of vascular permeability(GO:0043114) |
| 0.0 |
0.1 |
GO:0071624 |
positive regulation of granulocyte chemotaxis(GO:0071624) |
| 0.0 |
0.1 |
GO:0060325 |
face morphogenesis(GO:0060325) |
| 0.0 |
0.2 |
GO:0006477 |
protein sulfation(GO:0006477) |
| 0.0 |
0.2 |
GO:0071692 |
sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
| 0.0 |
0.1 |
GO:0070935 |
positive regulation of chemokine biosynthetic process(GO:0045080) 3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.0 |
0.2 |
GO:0030855 |
epithelial cell differentiation(GO:0030855) |
| 0.0 |
0.4 |
GO:0006750 |
glutathione biosynthetic process(GO:0006750) |
| 0.0 |
0.7 |
GO:0042531 |
positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
| 0.0 |
0.1 |
GO:0060744 |
thelarche(GO:0042695) development of secondary female sexual characteristics(GO:0046543) mammary gland branching involved in thelarche(GO:0060744) |
| 0.0 |
0.0 |
GO:0070544 |
histone H3-K36 demethylation(GO:0070544) |
| 0.0 |
0.2 |
GO:0006452 |
translational frameshifting(GO:0006452) positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
| 0.0 |
0.1 |
GO:0009756 |
carbohydrate mediated signaling(GO:0009756) |
| 0.0 |
1.4 |
GO:0006959 |
humoral immune response(GO:0006959) |
| 0.0 |
0.2 |
GO:0001510 |
RNA methylation(GO:0001510) |
| 0.0 |
0.1 |
GO:0060084 |
acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) synaptic transmission involved in micturition(GO:0060084) acetylcholine secretion(GO:0061526) |
| 0.0 |
1.1 |
GO:0051297 |
centrosome organization(GO:0051297) |
| 0.0 |
0.1 |
GO:0046618 |
drug transmembrane transport(GO:0006855) tetracycline transport(GO:0015904) drug export(GO:0046618) |
| 0.0 |
0.6 |
GO:0006309 |
DNA catabolic process, endonucleolytic(GO:0000737) apoptotic DNA fragmentation(GO:0006309) |
| 0.0 |
0.1 |
GO:0006296 |
nucleotide-excision repair, DNA incision, 5'-to lesion(GO:0006296) |
| 0.0 |
1.0 |
GO:0006888 |
ER to Golgi vesicle-mediated transport(GO:0006888) |
| 0.0 |
0.5 |
GO:0007257 |
activation of JUN kinase activity(GO:0007257) |
| 0.0 |
0.5 |
GO:0007229 |
integrin-mediated signaling pathway(GO:0007229) |
| 0.0 |
0.1 |
GO:0035313 |
wound healing, spreading of epidermal cells(GO:0035313) wound healing, spreading of cells(GO:0044319) epiboly(GO:0090504) epiboly involved in wound healing(GO:0090505) |
| 0.0 |
0.4 |
GO:0090630 |
activation of GTPase activity(GO:0090630) |
| 0.0 |
0.5 |
GO:0006397 |
mRNA processing(GO:0006397) |
| 0.0 |
0.4 |
GO:0006825 |
copper ion transport(GO:0006825) |
| 0.0 |
0.3 |
GO:0001938 |
positive regulation of endothelial cell proliferation(GO:0001938) |
| 0.0 |
0.1 |
GO:0045003 |
DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.0 |
0.3 |
GO:0071577 |
zinc II ion transmembrane transport(GO:0071577) |
| 0.0 |
0.3 |
GO:0031055 |
DNA replication-independent nucleosome assembly(GO:0006336) chromatin remodeling at centromere(GO:0031055) CENP-A containing nucleosome assembly(GO:0034080) DNA replication-independent nucleosome organization(GO:0034724) CENP-A containing chromatin organization(GO:0061641) |
| 0.0 |
0.1 |
GO:0051026 |
chiasma assembly(GO:0051026) |
| 0.0 |
0.0 |
GO:0016554 |
cytidine to uridine editing(GO:0016554) |
| 0.0 |
0.3 |
GO:0030838 |
positive regulation of actin filament polymerization(GO:0030838) |
| 0.0 |
0.1 |
GO:0030157 |
pancreatic juice secretion(GO:0030157) |
| 0.0 |
0.1 |
GO:0016575 |
histone deacetylation(GO:0016575) |
| 0.0 |
0.1 |
GO:0006553 |
lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
| 0.0 |
0.2 |
GO:0006268 |
DNA unwinding involved in DNA replication(GO:0006268) |
| 0.0 |
1.6 |
GO:0030155 |
regulation of cell adhesion(GO:0030155) |
| 0.0 |
0.2 |
GO:0046037 |
GMP metabolic process(GO:0046037) |
| 0.0 |
0.3 |
GO:0006099 |
tricarboxylic acid cycle(GO:0006099) |
| 0.0 |
0.9 |
GO:0031295 |
lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
| 0.0 |
0.0 |
GO:0036072 |
intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
| 0.0 |
0.4 |
GO:1900181 |
negative regulation of protein import into nucleus(GO:0042308) negative regulation of protein localization to nucleus(GO:1900181) negative regulation of protein import(GO:1904590) |
| 0.0 |
0.1 |
GO:0042976 |
activation of Janus kinase activity(GO:0042976) activation of JAK2 kinase activity(GO:0042977) |
| 0.0 |
0.1 |
GO:0002860 |
natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002420) natural killer cell mediated immune response to tumor cell(GO:0002423) regulation of natural killer cell mediated immune response to tumor cell(GO:0002855) positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002858) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
| 0.0 |
0.1 |
GO:0006707 |
cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.0 |
0.2 |
GO:0007191 |
adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
| 0.0 |
0.1 |
GO:0017121 |
phospholipid scrambling(GO:0017121) |
| 0.0 |
0.1 |
GO:0006689 |
ganglioside catabolic process(GO:0006689) |
| 0.0 |
0.3 |
GO:0006672 |
ceramide metabolic process(GO:0006672) |
